iShares U.S. Consumer Staples ETF
IYKDividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| December 19, 2025 | $0.70 | 2025-12-16 | 2025-12-16 |
| September 19, 2025 | $0.45 | 2025-09-16 | 2025-09-16 |
| June 20, 2025 | $0.41 | 2025-06-16 | 2025-06-16 |
| March 21, 2025 | $0.29 | 2025-03-18 | 2025-03-18 |
| December 20, 2024 | $0.52 | 2024-12-17 | 2024-12-17 |
Dividends Summary
- Consistent Payer: iShares U.S. Consumer Staples ETF has rewarded shareholders with 76 dividend payments over the past 18 years.
- Total Returned Value: Investors who held IYK shares during this period received a total of $43.85 per share in dividend income.
- Latest Payout: The most recent dividend of $0.70/share was paid 35 days ago, on December 19, 2025.
- Yield & Schedule: IYK currently pays dividends quarterly with an annual yield of 2.63%.
- Dividend Growth: Since 2007, the dividend payout has grown by 151.8%, from $0.28 to $0.70.
Company News
Coca-Cola announced major leadership changes with Henrique Braun becoming CEO on March 31, 2026, replacing James Quincey who will become Executive Chairman. The company created a new Chief Digital Officer role and reorganized its market leadership structure to strengthen consumer focus and accelerate technology adoption. Stock traded lower on the...
The article compares two consumer staples ETFs, XLP and IYK, analyzing their expense ratios, dividend yields, holdings, and performance. The author ultimately recommends XLP for its lower costs, higher yield, and strong holdings in Walmart and Costco.
Kraft Heinz is selling its Italian infant food brands Plasmon, Nipiol, Dieterba, Aproten, and Biaglut to NewPrinces Group, including a 300-employee manufacturing plant in Latina, with the deal expected to close by year-end 2025.
JAB, an investment holding company, has increased its stake in coffee company JDE Peet's to 68% by acquiring 86 million shares from Mondelez International. This move strengthens JAB's hold on the company as Mondelez sells off its stake.
Procter & Gamble reported mixed Q1 results, with sales slightly missing estimates but adjusted EPS beating expectations. The company reaffirmed its FY25 guidance for 2-4% all-in sales growth.
